Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Participants taking the placebo achieved a total mean weight loss of 3.8% (4.1 kg or 9.0 lbs.) from study entry over 84 weeks
The drugs have been shown in studies to reduce the risk of heart and kidney disease and lower average blood sugar levels in people with type 1 diabetes
As stated, the WL effects of GLP-1RAs are notable, and potential additional benefits should also be considered, especially in managing comorbidities such as diabetes and cardiovascular risk factors
Miura M, Igarashi M, Isotani R, Nakagawa-Nagahama Y, Kuranami S, Naruse K, et al
You can read the full article at The importance of weight reduction for improved health outcomes in individuals with obesity and type 2 diabetes is evident
How do I access this therapy
US$ 27.28
US$ 22.92
US$ 27.66
US$ 27.59
